Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: M-Mometasone
Active Ingredient: Mometasone furoate 1.02mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Patalganga Industrial Area, District Raigad (Maharashtra), India
Product: Salamol CFC-Free Inhaler
Active Ingredient: Salbutamol sulphate 29.64mg equivalent to salbutamol 100Ág/actuation
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Norton Healthcare Limited
Manufacturer: Norton (Waterford) Limited, T/A Ivax Pharmaceuticals Ireland, Cork Road, Waterford, Ireland
Dated this 26th day of November 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).